Clinical trial
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
NCT05918510 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 4, 2022
- Completion date
- April 4, 2029
- Enrollment
- 142 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carcinomas of unknown primary site, high-risk human papillomavirus infection, liquid biopsy, lymph node metastasis, occult tumor of the head and neck area, squamous cell carcinoma of the oropharynx